Smith KJ, Bland M, Clyde M, Garipy G, Pag V, Badawi G, et al
Safety considerations for GLP-1 receptor agonist use in post-bariatric surgery patients require careful attention, as this population may have unique vulnerabilities and altered pharmacokinetics compared to patients without surgical history
Clare Mackay, Oxford Centre for Human Brain Activity, Wellcome Centre for Integrative Neuroimaging, Department of Psychiatry, University of Oxford, Oxford, United Kingdom
For example, exenatide reduces the peak concentration of ethinyl estradiol by 15% to 45%, depending on timing, while liraglutide decreases it by 12%